Global Information
회사소개 | 문의

면역항암제 개발 동향 : 분석 툴

Immuno-Oncology Drug Development: Analytical Tool

리서치사 BioSeeker Group AB
발행일 2018년 09월 상품 코드 710759
페이지 정보 영문
US $ 4,450 ₩ 5,052,500 Desktop App plus Online Access to Updates (One Year) - Single User
US $ 8,900 ₩ 10,105,000 Desktop App plus Online Access to Updates (One Year) - Site License
US $ 13,350 ₩ 15,157,500 Desktop App plus Online Access to Updates (One Year) - Global License

면역항암제 개발 동향 : 분석 툴 Immuno-Oncology Drug Development: Analytical Tool
발행일 : 2018년 09월 페이지 정보 : 영문

면역항암제(Immuno-Oncology Drug) 개발에 종사하는 1,204개사 이상과 파트너 기업의 파이프라인 동향을 집계하였으며, 3,691개의 파이프라인 의약품(그 중 2,752개가 617종의 표적을 대상으로 한 적극적인 개발 단계)에 관한 각종 데이터를 온라인 액세스에서 제공하고 있습니다.

1. 제공 내용

  • 분석 툴
    • 1년간 온라인 액세스
    • 내용과 특집 격주 업데이트
    • 파이프라인 앨럿(pipeline alerts)
    • 온라인 서포트
  • 1stOncology NewsDesk 액세스
    • 뉴스 속보 라이브 스트림(5분마다 업데이트)
    • 각종 채널
      • 소셜 미디어
      • 임상시험
      • 지식재산
      • 재무 데이터
      • 프레스릴리스

2. 아래 사항에 관심을 갖고 계신 분에게 추천합니다.

  • 타겟 스카우팅
  • 초기/후기 단계 파이프라인 분석
  • 바이오마커/동반진단 의약품 분석
  • 계약 및 제휴 분석
  • 병용요법 분석
  • 임상시험 결과 분석
  • 적응증 선정 및 확대 분석
  • First-in-Class 분석
  • 신약 재창출(Drug repositioning)
  • 파이프라인 분석 : 표적 경로별
LSH 18.10.10

Immuno-Oncology (I-O) has quickly become to be the 4th pillar of cancer therapy and encompasses a highly diverse portfolio of treatment strategies from the early interferon-α/interleukin-2 therapies to the current progress of immune-checkpoint inhibitors and CAR-T therapies to make the immune system fight cancer.

Immuno-Oncology Drug Development: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot and fast moving area in oncology. This unique product is truly the only one of its kind and is designed to give you a competitive edge in your I-O drug intelligence.

Your Immuno-Oncology Drug Development: Analytical Tool is based on two decades of proven methodology in serving clients with interest in:

  • Target Scouting
  • Early & Late Stage Pipeline Analysis
  • Biomarker/Companion Diagnostic Analysis
  • Deal & Alliance Analysis
  • Combination Therapy Analysis
  • Clinical Trial Results Analysis
  • Indication Selection & Expansion Analysis
  • First-in-Class Analysis
  • Drug Repositioning
  • Pipeline Analysis by Targeted Pathways

Analytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this tool you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf.

Your Immuno-Oncology Drug Development: Analytical Tool covers more than 1204 companies plus partners who are today developing 3691 I-O drugs where of 2752 are in active developmental in cancer across 617 different targets. Any data and/or analysis from the Analytical Tool is yours to keep and data/graphs/tables can be easily exported into Excel/PDF and various graphic formats for mixing with your own proprietary information.

Let our expertise work for you

While executing some of your daily tasks in our Analytical Tools, you will benefit from almost two decades of our experience in perfecting features and analysis, allowing you to easily create breakdowns, tables, graphs and exports for your reports, presentations and conference attendance via our easy to use point and click interface.

Support and inspiration at your finger-tips

You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed

Unlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of free online access to twice-weekly updates in both contents and features, pipeline alerts and online support. You can choose to renew your access to these updates and support on a yearly basis or go over to our industry leading full service platform covering all oncology drug development, 1stOncology.

Your key to accessing the 1stOncology NewsDesk

As a special bonus, your Analytical Tool unlocks lifetime(*) access to the 1stOncology Newsdesk! This service, which is normally reserved for full 1stOncology users only, is a live stream of breaking news within the oncology industry. Updated every 5 minutes, you can tune in to specific channels such as Social Media, Clinical Trials, Intellectual Property, Financial data and Press Releases. This is a great tool to ensure your surveillance of your area of interest is complete.

Format & Free Updates

This is 12 months of access to an ever-green Analytical Tool that you access simply online. It is continuously updated with new information and analysis throughout your 12 month access period, ensuring that you stay up to date with this fast moving field. At the end of your access period, if you so wish, you can choose to renew.

System Requirements

  • Browser Application (Supports: Internet Explorer, FireFox, Chrome and Safari))
  • Internet access

(*) In this context, lifetime access refers to the full period of time that BioSeeker Group offers a Newsdesk product or similar news based service.

Back to Top
전화 문의
BCC Research